Items Tagged ‘#biologics’
February 16, 2023
Recognizing the potential of gene-modified T cells to transform medicine, researchers at the University of Pennsylvania have continued to innovate with clinical trials over the past two decades. In a convergence of science, medicine and entrepreneurship, an industry collaborator brought the first breakthrough gene therapy for cancer to market in the U.S. in 2017 — […]
Tags: #biologics, #CAR T-cell therapy, #Dr. Bruce Levine, #Dr. Richard Hayden, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
January 12, 2023
Reprogramming stem cells to heal disease
At one point, Shinya Yamanaka, M.D., Ph.D., was so down and discouraged that he almost gave up his research into embryonic cells and their powerful potential to replace diseased cells. He was finding little interest among colleagues; funding was hard to come by; and research journals rejected his studies. Then, discovery of human embryonic cell […]
Tags: #biologics, #Dr. Shinya Yamanaka, #induced pluripotent stem cells, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
December 19, 2022
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: #biologics, #Biomanufacturing, #cell therapy, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Biotherapeutics, CAR-T cell therapy
August 15, 2022
Mayo Clinic announces a strategic collaboration for a new era of biomanufacturing
Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together science, engineering and manufacturing to advance Mayo Clinic’s vision of bringing new cures to clinical care. The focus will be on therapies derived from human sources known as biologics — cells, blood, enzymes, […]
Tags: #biologics, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Medicine, #National Resilience Inc.
June 27, 2022
Biomanufacturing 101: Understanding a new era of therapeutics
Advancing cellular discoveries from clinical trials to commercial therapy is a cornerstone of Mayo Clinic’s strategic emphasis on biomanufacturing. The long-term vision is to provide new cures for patients with unmet needs. “Biomanufacturing is a type of manufacturing that utilizes sources from the human body — cells, blood, enzymes, tissues, genes or genetically engineered cells […]
Tags: #biologics, #biotherapeutics, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine, #stem cell research